Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Bowlus

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Endoscopy International Open|February 16, 2024
Per-oral cholangioscopy in patients with primary sclerosing cholangitis: a 12-month follow-up studyRachid Mohamed, Sooraj Tejaswi, Lars Aabakken, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2013
Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based studyMoon S Chen, Dao M Fang, Susan L Stewart, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Cellular & Molecular Immunology|September 22, 2015
The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosisTakashi Tomiyama, Guo-Xiang Yang, Ming Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2026
IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell InjuryXing Zhou, Shuyu Shao, Danning Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With PruritusCynthia Levy, Stuart Kendrick, Christopher L Bowlus, et al.
Hepatology Communications|March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS StudyBertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Hepatology Communications|July 5, 2024
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitisDouglas Thorburn, Diana J Leeming, William T Barchuk, et al.
Journal of Autoimmunity|September 25, 2023
The gut ecosystem and immune toleranceTihong Shao, Ronald Hsu, Desiree L Rafizadeh, et al.
Alcoholism, Clinical and Experimental Research|November 3, 2011
S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trialValentina Medici, Maria C Virata, Janet M Peerson, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Endoscopy International Open|February 16, 2024
Per-oral cholangioscopy in patients with primary sclerosing cholangitis: a 12-month follow-up studyRachid Mohamed, Sooraj Tejaswi, Lars Aabakken, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2013
Increasing hepatitis B screening for hmong adults: results from a randomized controlled community-based studyMoon S Chen, Dao M Fang, Susan L Stewart, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitisMichael Trauner, Yevgeniy Gindin, Zhaoshi Jiang, et al.
Cellular & Molecular Immunology|September 22, 2015
The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosisTakashi Tomiyama, Guo-Xiang Yang, Ming Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2026
IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell InjuryXing Zhou, Shuyu Shao, Danning Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With PruritusCynthia Levy, Stuart Kendrick, Christopher L Bowlus, et al.
Hepatology Communications|March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS StudyBertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Hepatology Communications|July 5, 2024
Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitisDouglas Thorburn, Diana J Leeming, William T Barchuk, et al.
Journal of Autoimmunity|September 25, 2023
The gut ecosystem and immune toleranceTihong Shao, Ronald Hsu, Desiree L Rafizadeh, et al.
Alcoholism, Clinical and Experimental Research|November 3, 2011
S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trialValentina Medici, Maria C Virata, Janet M Peerson, et al.
Pageof 19